secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACURA PHARMACEUTICALS, INC (—)
CIK:        0000786947
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001104659-26-056748
Event type: debt
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 2.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acura's debt to related party grows to $10.3M; warns of possible shutdown without new financing by May-end
--------------------------------------------------------------------------------

- Received four $100,000 loans from Abuse Deterrent Pharma on March 30, April 3, April 20, May 5, 2026, bringing principal to $10,294,279.
- Accrued interest ~$1,090,000 as of May 5; interest rate 5.25% (7.5% on default).
- Without additional financing by end of May 2026, company will need to scale back operations, furlough employees, or seek bankruptcy.
- AD Pharma, which owns ~65% of Acura's common stock, is controlled by Mr. Schutte, who also owns ~13% directly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/786947/000110465926056748/0001104659-26-056748-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/786947/000110465926056748/tm2613771d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-056748

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer